- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01853995
Mechanism of Class II Correction With Fixed Lingual Mandibular Growth Modificator (FLMGM) (FLMGM)
Class II Division 1 Malocclusions Treated With Fixed Lingual Mandibular Growth Modificator (FLMGM): The Mechanism of Sagittal Occlusal Correction
The aim of the current controlled trial was to assess the possible net skeletal and dental effects of FLMGM treatment in relation to growth with emphasis on the contribution of skeletal and dental changes to sagittal correction of Cl II/1 malocclusion.
The null hypothesis stated that there were no significant differences in dentoskeletal changes between FLMGM treated group and control untreated group.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The current study was prospective, controlled, parallel groups, clinical trial conducted at the department of Orthodontics between May 2009 and June 2011. The protocol of study was approved by the council of scientific research and postgraduate studies, on the 5/April/2009.
Of the 43 patients initially enrolled, 38 completed this trial and comprised the final sample, and 5 (4 treated, 1 untreated) were excluded.
The final sample comprised 38 subjects who completed this trial. All patients and parents gave prior informed consent to their inclusion in the investigation.
Patients of both groups were followed on a parallel basis during a period of 8 months and the trial included all patients regardless of achievement of a Class I incisor relationship. All patient of treatment group (n=21) were treated using FLMGM without extractions or any other form of orthodontic treatment, though the treatment was continued beyond this time point if the Class II malocclusion was not fully corrected and clinical objectives were not achieved. On the other hand, no orthodontic treatment was performed during that duration for the subjects of control group (n=17), and most of control subjects were offered suitable treatment at a later date.
For each patient, a direct digital lateral cephalogram was taken pre- and post- treatment/observation using PAX 400 (VATECH CO., Korea) with the same settings. All cephalograms were digitized on screen by a cursor-driven mouse and analyzed in a blind manner by the same orthodontist using a commercial cephalometric software (Viewbox, version 3.1.1.13, dHAL Software, Kifissia , Hellas, Greece). All measurements were reduced to life size (radiographic enlargement of 7.54 % in the median plane).
At the end of the treatment/observation period, sagittal occlusal (SO) analysis, according to the method of Pancherz modified by Franchi et al, was applied to assess sagittal occlusal changes and identify the mechanism of Class II correction. Moreover, the total mandibular length (Condyle-Gnathion) was measured.
The sample was used as a whole and not differentiated by sex. Pretreatment equivalence and comparison of changes observed in the FLMGM and control groups were tested for significance with independent-sample t-test using SPSS, version 16.0. Changes occurring during the examination period in each group were tested with paired-sample t-test. P values of less than 0.05 were considered statistically significant.
To assess the method error, twenty cephalograms were picked at random from the treatment and control groups and redigitized and analyzed by the same orthodontist after an interval of 1 month, and the combined error of cephalometric method was calculated by Dahlberg's formula.
Study Type
Enrollment (Actual)
Phase
- Phase 2
Contacts and Locations
Study Locations
-
-
-
Damascus, Syrian Arab Republic
- Department of Orthodontics, School of Dentistry, University of Damascus
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Cl II/1 malocclusion with an overjet greater than 4 mm.
- Mild to moderate Class II Skeletal pattern (A-N-B > 4°) with retrognathic mandible (S-N-B < 76°).
- Growth potential. Fishman skeletal maturation indicator (SMI) method was used to assess the hand-wrist radiographs, and only patients in the peak of the pubertal growth spurt, which occurs on average between SMIs 4 to 7, at the beginning of the treatment/observation period were invited.
Exclusion Criteria:
- craniofacial syndromes
- clinically obvious facial asymmetry
- extreme vertical disproportion
- prior orthodontic therapy
- permanent tooth extractions
- significant medical history
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NON_RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: FLMGM Treatment Group
Cl II/1 patients treated with Fixed Lingual Mandibular Growth Modificator (FLMGM)
|
New Class II Corrector
Other Names:
|
NO_INTERVENTION: Untreated Class II Control Group
control group
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Overjet reduction and Class II molar correction
Time Frame: 8 months
|
8 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Total mandibular length (Co-Gn)
Time Frame: 8 months
|
8 months
|
Other Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Standard Dental and skeletal changes
Time Frame: 8 months
|
8 months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- FLMGM: Mechanism of Correction
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Class II Division 1 Malocclusion
-
Postgraduate Institute of Dental Sciences RohtakUnknownAngle Class II, Division 1 MalocclusionIndia
-
Al-Azhar UniversityCompleted3D Evaluation of Powerscope Appliance in Treatment of Skeletal Class 2 Malocclusion (Powerscope app)Class II Malocclusion, Division 1Egypt
-
Al-Azhar UniversityCompletedClass II Malocclusion, Division 1Egypt
-
Ain Shams UniversityCompletedClass II Malocclusion Division 1Egypt
-
Cairo UniversityUnknownClass II Malocclusion, Division 1
-
Hama UniversityCompletedMalocclusion | Class II Division 1 MalocclusionSyrian Arab Republic
-
T.C. ORDU ÜNİVERSİTESİRecruiting
-
University of ManchesterNational Health Service, United KingdomTerminatedClass II Division 1 MalocclusionUnited Kingdom
-
AL YousefKing Abdullah International Medical Research CenterUnknownMalocclusion, Angle Class I | Malocclusion; Angle Class II Division 1Saudi Arabia
-
Damascus UniversityCompletedClass II Malocclusion, Division 1Syrian Arab Republic
Clinical Trials on Fixed Lingual Mandibular Growth Modificator (FLMGM)
-
Damascus UniversityCompletedClass II Division 1 Malocclusion | Retrognathic MandibleSyrian Arab Republic